User:Mr. Ibrahem/Cetrorelix
Clinical data | |
---|---|
Trade names | Cetrotide, others |
Other names | Cetrorelix acetate |
AHFS/Drugs.com | Monograph |
Routes of administration | Subcutaneous injection |
Drug class | GnRH antagonist[1] |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 85% |
Protein binding | 86% |
Elimination half-life | 62.8 hours / 3 mg single dose; 5 hours / 0.25 mg single dose; 20.6 hours / 0.25 mg multiple doses |
Excretion | feces (5% to 10% as unchanged drug and metabolites); urine (2% to 4% as unchanged drug) |
Identifiers | |
| |
Chemical and physical data | |
Formula | C70H92ClN17O14 |
Molar mass | 1431.06 g·mol−1 |
| |
(what is this?) (verify) |
Cetrorelix , sold under the brand name Cetrotide, is a medication used in fertility treatment to prevent early ovulation in women getting ovarian stimulation.[2] It is given by injection under the skin.[3]
Common side effects include ovarian hyperstimulation syndrome, nausea, and headache.[1] Other side effects may include anaphylaxis and liver problems.[1] Use during pregnancy may harm the baby.[1] It is a gonadotropin-releasing hormone (GnRH) blocker.[1]
Cetrorelix was approved for medical use in Europe in 1999 and the United States in 2000.[2][1] In the United Kingdom 250 micrograms costs the NHS about £27 as of 2021.[3] This amount in the United States costs about 250 USD.[4]
References[edit]
- ^ a b c d e f g "Cetrorelix Monograph for Professionals". Drugs.com. Archived from the original on 4 February 2021. Retrieved 3 January 2022.
- ^ a b c "Cetrotide". Archived from the original on 16 May 2021. Retrieved 3 January 2022.
- ^ a b BNF 81: March-September 2021. BMJ Group and the Pharmaceutical Press. 2021. p. 778. ISBN 978-0857114105.
- ^ "Cetrorelix Prices, Coupons & Savings Tips - GoodRx". GoodRx. Retrieved 3 January 2022.